304am永利集团|·主頁(歡迎您)

Be the most trusted biotech company

2018-05-24

Important News! Henlius Completed Its First Phase III Study of HLX01(Rituximab Injection)
2018-05-22

Henlius Formed Scientific Advisory Board (SAB)
2018-05-10

China's Global Investment Push Opens Doors for Domestic Biotechs
2018-03-01

Hail! Shanghai Henlius Biotech, Inc. is Honored as the Annual Preeminence of Asia Biotech of 2017
2018-01-22

Innovation-driven Development | Market Capitalization of Henlius Biotech Hits CNY 10 Billion
2016-12-13

Licensing Cooperation Between Fosun Pharma’s Monoclonal Antibody Platform Henlius and Korea’s AbClon
2016-10-31

Henlius Completed Phase I Clinical Study of Its New Drug for Breast Cancer
2016-10-17

Henlius Biosimilar Innovation Breakthrough